Revisiting traditional risk factors for rejection and graft loss after kidney transplantation
about
Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytologyAlloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenHLA antibody detection with solid phase assays: great expectations or expectations too great?The Complement System and Antibody-Mediated Transplant RejectionTherapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine.Predicting alloreactivity in transplantation.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Significance of pre-transplant anti-HLA antibodies detected on an ELISA mixed antigen tray platform.Quantifying renal allograft loss following early antibody-mediated rejection.The role of donor-specific HLA alloantibodies in liver transplantation.Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic riskUtility of HLA Antibody Testing in Kidney Transplantation.A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control StudyDonor-specific antibodies adversely affect kidney allograft outcomes.The paradoxical functions of B cells and antibodies in transplantationA time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A.Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy.Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.B-cell regulation and its application to transplantation.Pretransplant identification of acute rejection risk following kidney transplantation.The increasing clinical importance of alloantibodies in kidney transplantation.Intraoral features and considerations in face transplantation.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival.Ischaemic and inflammatory injury in renal graft from brain death donation: an update review.De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience.Accommodation and related conditions in vascularized composite allografts.Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients.Biomarkers in kidney transplantation: From bench to bedside.Treatment of Antibody-Mediated Rejection After Kidney Transplantation - 10 Years' Experience With Apheresis at a Single Center.Over ten-year kidney graft survival determinants.Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients.Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.Influence of test technique on sensitization status of patients on the kidney transplant waiting list.Quantifying the risk of incompatible kidney transplantation: a multicenter study.Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
P2860
Q26744274-8BA99629-D28A-4966-A206-1E41F52538F9Q26766411-7B28C0B7-5110-488C-B686-7FD58DF13599Q27015921-6129CBB9-648B-473A-81B9-F4E9E22BA3C6Q28087773-F15FC78A-AA07-4E1E-9F8D-F61E9A405B2DQ30456482-F1B30570-3095-46EC-83E3-28292458122CQ33608371-44976218-22D5-486C-9633-63C8D563DBE4Q34841849-B749BC09-C868-4E80-BE43-0CAFEE8FBDBAQ34992152-EE5A8F0C-EF91-409C-9AED-C1A8274855B8Q35007419-80355840-267F-4718-97DA-FAF311436A91Q35547041-112C2279-FA0B-4F31-BE4E-819288AFC90FQ35550570-B4A8F249-CF1C-4DCF-BC0A-7A04AE7B130AQ35649082-1B88650D-EADF-4D29-ACC1-6E725CF910A9Q35790601-A474DE50-DC69-412D-8209-506770737793Q36194995-989E6383-6557-4C1B-967A-D1DCC26FF869Q36426146-0BEE573A-5F82-4ED6-A697-0B1B4067E22FQ36563918-E2AD6376-0A79-4B5D-885B-EB5D96321746Q37219058-E6FAAE5C-5DA5-424B-9F02-C87DBE097412Q37660263-13DD2BC4-C0BA-4093-B7DD-17082111BD90Q38022711-59887FEF-43E2-40B9-86DB-F269272E2888Q38126085-ADF28518-53A9-45D9-98F6-C682D21FEE2FQ38151922-6E0FB77F-02F6-407B-890D-BE5DCA484028Q38258153-3F056AB4-4DC1-45BF-89EE-216241FB60A2Q38270985-84BF29C8-9D83-4C2D-953C-E2E7061446E1Q38429887-48D8E22F-A436-4921-BD8B-E8D02D423CA6Q38690664-BC0278F6-3122-4276-8FA6-DFBAA143867FQ38861456-61E73905-3374-44EA-B745-517CEC64E25DQ39149426-3C33160E-9568-4598-9C41-EF456DCCBD0BQ39418200-181D7F45-7420-4A17-80B9-518EBDE534F2Q40244185-653FB542-BD35-48DD-A780-C1C0E6AA617AQ41500055-552386EC-CD9F-47D0-8A95-1A6E2326E37EQ41832482-8D60F64B-5082-4D4C-83CB-4FD476F93AFEQ42102593-025C8982-33A5-4F87-9D84-8E3D2AFE3050Q42356322-1A3E933C-0213-412F-BFBB-223EF13EFB13Q43681319-DF4B9361-8B6C-4B08-9A67-21C65F5F453DQ44205594-C6A17EEA-9002-4363-A0E8-BB2EB0A6E7AFQ44371693-4F534B4C-BD1C-4DB7-A18B-08B65AC98705Q44753304-F2B3D51F-28F9-491D-8461-214029816021Q45972310-CDA69DB4-3FFF-4ABF-80E2-87BFED5B5092Q46938131-B765B7FA-AA9F-473F-BC6B-6A67E0ECE7A0Q47313617-D4798F71-4483-46D9-B9F2-4D49DB04C7CA
P2860
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Revisiting traditional risk fa ...... s after kidney transplantation
@ast
Revisiting traditional risk fa ...... s after kidney transplantation
@en
type
label
Revisiting traditional risk fa ...... s after kidney transplantation
@ast
Revisiting traditional risk fa ...... s after kidney transplantation
@en
prefLabel
Revisiting traditional risk fa ...... s after kidney transplantation
@ast
Revisiting traditional risk fa ...... s after kidney transplantation
@en
P2093
P2860
P1476
Revisiting traditional risk fa ...... s after kidney transplantation
@en
P2093
K Gillingham
O G Ozturk
T L Pruett
P2860
P304
P356
10.1111/J.1600-6143.2011.03640.X
P407
P50
P577
2011-08-03T00:00:00Z